These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9527077)

  • 1. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus.
    Osanai H; Kanayama H; Miyazaki Y; Fukushima A; Shinoda M; Ito T
    Am J Cardiol; 1998 Mar; 81(6):698-701. PubMed ID: 9527077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced secretion of insulin plays a role in the development of atherosclerosis and restenosis of coronary arteries: elective percutaneous transluminal coronary angioplasty in patients with effort angina.
    Nishimoto Y; Miyazaki Y; Toki Y; Murakami R; Shinoda M; Fukushima A; Kanayama H
    J Am Coll Cardiol; 1998 Nov; 32(6):1624-9. PubMed ID: 9822088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
    Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients.
    Babalik E; Gürmen T; Orhan L; Bulur H; Gülbaran M; Ersanli M; Oztürk S
    Catheter Cardiovasc Interv; 2003 Mar; 58(3):306-12. PubMed ID: 12594693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
    Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
    Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase in the delta ST/delta heart rate (HR) index: a new predictor of restenosis after successful percutaneous transluminal coronary angioplasty.
    Hamasaki S; Arima S; Tahara M; Kihara K; Shono H; Nakao S; Tanaka H
    Am J Cardiol; 1996 Nov; 78(9):990-5. PubMed ID: 8916476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables.
    Johansen O; Abdelnoor M; Brekke M; Seljeflot I; Høstmark AT; Arnesen H
    Scand Cardiovasc J; 2001 Mar; 35(2):86-91. PubMed ID: 11405502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.
    Hearn JA; Donohue BC; Ba'albaki H; Douglas JS; King SB; Lembo NJ; Roubin GS; Sgoutas DS
    Am J Cardiol; 1992 Mar; 69(8):736-9. PubMed ID: 1532112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.
    Cooke T; Sheahan R; Foley D; Reilly M; D'Arcy G; Jauch W; Gibney M; Gearty G; Crean P; Walsh M
    Circulation; 1994 Apr; 89(4):1593-8. PubMed ID: 8149526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting.
    Piatti P; Di Mario C; Monti LD; Fragasso G; Sgura F; Caumo A; Setola E; Lucotti P; Galluccio E; Ronchi C; Origgi A; Zavaroni I; Margonato A; Colombo A
    Circulation; 2003 Oct; 108(17):2074-81. PubMed ID: 14530196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of restenosis 10 years after coronary angioplasty.
    Espinola-Klein C; Rupprecht HJ; Erbel R; Nafe B; Brennecke R; Meyer J
    Eur Heart J; 1998 Jul; 19(7):1047-53. PubMed ID: 9717040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new predictor of restenosis after successful percutaneous transluminal coronary angioplasty in patients with multivessel coronary artery disease.
    Hamasaki S; Abematsu H; Arima S; Tahara M; Kihara K; Shono H; Nakao S; Tanaka H
    Am J Cardiol; 1997 Aug; 80(4):411-5. PubMed ID: 9285650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose dobutamine testing using contrast left ventriculography in the same session as coronary angiography predicts the improvement of left ventricular function after coronary angioplasty in postinfarction patients.
    Sanchis J; Bodí V; Insa L; Gómez-Aldaraví R; Berenguer A; López-Lereu MP; Chorro FJ; López-Merino V
    Am J Cardiol; 1999 Jan; 83(1):15-20. PubMed ID: 10073778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.